Respiratory Care Year in Review 2012: Invasive Mechanical Ventilation, Noninvasive Ventilation, and Cystic Fibrosis

Kallet, Richard H; Volsko, Teresa A; Hess, Dean

doi:10.4187/respcare.02412

Cited by 9 publications

(11 citation statements)

References 63 publications

(51 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We previously reviewed invasive ventilation, noninvasive ventilation, and cystic fibrosis. 1 In this paper we publish topics related to asthma and sleep-disordered breathing (SDB).…”

Section: Introductionmentioning

confidence: 99%

Respiratory Care Year in Review 2012: Asthma and Sleep-Disordered Breathing

2013

Self Cite

View full text Add to dashboard Cite

Asthma has long been recognized as a common respiratory disease, and the recognition of sleepdisordered breathing is becoming more prevalent. Patients with these disorders are commonly seen by clinicians caring for patients with respiratory disease. There is also much academic interest in asthma and sleep-disordered breathing. The purpose of this paper is to review the recent literature related to asthma and sleep-disordered breathing in a manner that is most likely to have interest to the readers of RESPIRATORY CARE.

show abstract

“…We previously reviewed invasive ventilation, noninvasive ventilation, and cystic fibrosis. 1 In this paper we publish topics related to asthma and sleep-disordered breathing (SDB).…”

Section: Introductionmentioning

confidence: 99%

Respiratory Care Year in Review 2012: Asthma and Sleep-Disordered Breathing

2013

Self Cite

View full text Add to dashboard Cite

show abstract

“…Based on this finding, we hypothesized that, patients with lower FEV1 0M values had advanced airway destruction and fixed obstruction, resulting in partly restricted admission of inhaled tiotropium. Pulmonary exacerbations are promoted by inflammation and negatively influenced mucociliary clearance, which contribute to a worsening airway obstruction, a decline in lung function, and a profound negative impact on perceived quality of life [ 2 ]. As pulmonary exacerbations have very severe consequences in CF, both in terms of current morbidity as well as implications for long-term morbidity and mortality, the reduction of exacerbation risk is one goal of CF treatment [ 2 , 33 ].…”

Section: Discussionmentioning

confidence: 99%

“…Cystic Fibrosis (CF) is a life-limiting autosomal recessive disorder that affects more than 70,000 individuals worldwide [ 1 , 2 ]. Chronic airway infection, bronchiectasis, hypoxemia and hypercapnia as well as defective mucociliary clearance and bronchial and mucus obstruction are key features of the CF respiratory disease, resulting in a progressive lung function decline.…”

Section: Introductionmentioning

confidence: 99%

Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis

et al. 2016

View full text Add to dashboard Cite

BackgroundChronic lung disease is the leading cause of death in patients with Cystic Fibrosis (CF) and is often treated with bronchodilators. It is not known whether long-term tiotropium bromide treatment may have a positive impact on lung function.MethodsThis retrospective cohort study estimated annual lung function decline utilizing longitudinal data for forced expiratory volume in 1 s (FEV1).ResultsA total of 160 adult patients with CF were analyzed. The subjects treated for 24 months with tiotropium bromide had a significantly slower decline of mean annual change of FEV1 (treated: -0.3±4.0%; control: -2.3±5.0%; p = 0.0130). In patients with FEV1 ≥70% predicted, long-term tiotropium bromide treatment was associated with greater improvements in annual lung function decline (FEV1 ≥70% predicted: treated: +0.5±4.7%; control: -4.0±6.3%; p = 0.0132; FEV1 50–69% predicted: treated: -0.5±4.4%; control: -0.8±3.8%; p = 0.7142; FEV1 ≤49% predicted: treated: -0.6±3.4%; control: -2.4±4.8%; p = 0.0898).ConclusionThis study suggests that long-term tiotropium bromide treatment may be associated with reduced annual decline of FEV1 in patients with CF, particularly in adults with a mild degree of severity.

show abstract

“…Subjects were randomized into HFOT and helmet NIV groups. A significantly lower incidence of intubation in the helmet NIV group than in the HFOT group (30% vs. 51%; difference, -21% [95% CI -38% to -3%]; p=0.03) and a higher number of invasive mechanical ventilation-free days at 28 days in the helmet NIV than in the high-flow nasal oxygen group (28 [IQR,[13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] vs [25][26][27][28]10 .…”

mentioning

confidence: 99%

Noninvasive Mechanical Ventilation in COVID-19 Related Acute Respiratory Failure

Pavliša

2023

ACC

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is presented with a wide range of symptoms, from asymptomatic disease to severe and progressive interstitial pneumonia. As part of interstitial pneumonia, respiratory failure is typically presented as hypoxia and is the most common cause of hospitalization. When oxygen therapy fails, continuous positive airway pressure (CPAP) or noninvasive mechanical ventilation (NIV) are used as respiratory support measures of first choice. Noninvasive respiratory support (NIRS) is applied in order to save intensive care unit resources and to avoid complications related to invasive mechanical ventilation. Emerging evidence has shown that the use of CPAP or NIV in the management of acute hypoxemic respiratory failure in COVID-19 reduces the need for intubation and mortality. The advantage of NIRS is the feasibility of its application on wards. NIV could be administered via a face mask or helmet interface. Helmet adheres better than mask and therefore leakage is reduced, a delivery of positive end-expiratory pressure is more accurate, and the risk of nosocomial transmission of infections is lowered. Patients on NIRS must be carefully monitored so that further respiratory deterioration is not overlooked and additional measures of care including timely intubation and invasive mechanical ventilation could be performed if needed.

show abstract

Respiratory Care Year in Review 2012: Invasive Mechanical Ventilation, Noninvasive Ventilation, and Cystic Fibrosis

Cited by 9 publications

References 63 publications

Respiratory Care Year in Review 2012: Asthma and Sleep-Disordered Breathing

Respiratory Care Year in Review 2012: Asthma and Sleep-Disordered Breathing

Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis

Noninvasive Mechanical Ventilation in COVID-19 Related Acute Respiratory Failure

Contact Info

Product

Resources

About